Neuro-Oncology Reviews




Volume 24 Number 7
15 April 2022




Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 7, 15 April






Lutz K, Jünger ST, Messing-Jünger M.
Essential Management of Pediatric Brain Tumors.
Children (Basel). 2022 Apr 2;9(4):498
. doi: 10.3390/children9040498. PMID: 35455542. Review. ˍ



*

Aslan F, Günaydın E, Yukruk F, Güvenç İ, Gençler OS.
Glioblastoma Multiforme With CDKN2A, Loss of PTEN and EGFR Amplification, and Diffuse Distant Organ Metastasis Treated With Six Lines of Therapy: A Case Report and Literature Review.
Cureus. 2022 Apr 3;14(4):e23796
. doi: 10.7759/cureus.23796. PMID: 35518520. Case report, Review. ˍ




Rao V, Kumar G, Vibhavari RJA, Nandakumar K, Thorat N, Chamallamudi MR, Kumar N.
Temozolomide Resistance: A Multifarious Review on Mechanisms Beyond O-6-Methylguanine-DNA Methyltransferase.
CNS Neurol Disord Drug Targets. 2022 Apr 4
. doi: 10.2174/1871527321666220404180944. PMID: 35379142. Review˰ ˍ




Cohen KJ, et al., PDQ Pediatric Treatment Editorial Board.
Childhood Astrocytomas Treatment (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ. 2022 Apr 5
. NCBI ID: NBK65944. PMID: 26389382. Review. ˍ




Shaffer A, Kwok SS, Naik A, Anderson AT, Lam F, Wszalek T, Arnold PM, Hassaneen W.
Ultra-High-Field MRI in the Diagnosis and Management of Gliomas: A Systematic Review.
Front Neurol. 2022 Apr 5;13:857825
. doi: 10.3389/fneur.2022.857825. PMID: 35449515. Review. ˍ




Aldoghachi AF, Aldoghachi AF, Breyne K, Ling KH, Cheah PS.
Recent Advances in the Therapeutic Strategies of Glioblastoma Multiforme.
Neuroscience. 2022 Apr 6:S0306-4522(22)00155-5
. doi: 10.1016/j.neuroscience.2022.03.030. PMID: 35395355. Review˰ ˍ



*

Grossen A, Smith K, Coulibaly N, Arbuckle B, Evans A, Wilhelm S, Jones K, Dunn I, Towner R, Wu D, Kim YT, Battiste J.
Physical Forces in Glioblastoma Migration: A Systematic Review.
Int J Mol Sci. 2022 Apr 6;23(7):4055
. doi: 10.3390/ijms23074055. PMID: 35409420. Review. ˍ




Johnson GW, Han RH, Smyth MD, Leuthardt EC, Kim AH.
Laser Interstitial Thermal Therapy in Grade 2/3 IDH1/2 Mutant Gliomas: A Preliminary Report and Literature Review.
Curr Oncol. 2022 Apr 8;29(4):2550-2563
. doi: 10.3390/curroncol29040209. PMID: 35448183. Observational study, Review. ˍ



*

Bianconi A, Aruta G, Rizzo F, Salvati LF, Zeppa P, Garbossa D, Cofano F.
Systematic Review on Tumor Microenvironment in Glial Neoplasm: From Understanding Pathogenesis to Future Therapeutic Perspectives.
Int J Mol Sci. 2022 Apr 9;23(8):4166
. doi: 10.3390/ijms23084166. PMID: 35456984. Review. ˍ




Gatto L, Di Nunno V, Franceschi E, Tosoni A, Bartolini S, Brandes AA.
Pharmacotherapeutic Treatment of Glioblastoma: Where Are We to Date?
Drugs. 2022 Apr 9;82(5):491-510
. doi: 10.1007/s40265-022-01702-6. PMID: 35397073. Review˰˰ ˍ ˍ




Li X, Jia Z, Yan Y.
Efficacy and safety of tumor-treating fields in recurrent glioblastoma: a systematic review and meta-analysis.
Acta Neurochir (Wien). 2022 Apr 9
. doi: 10.1007/s00701-022-05192-z. PMID: 35397674. Review, Meta-analysis˰ ˍ




Paun L, Lavé A, Patet G, Bartoli A.
Supratentorial Pediatric Midline Tumors and Tumor-like Lesions: Clinical Spectrum, Natural History and Treatment Options.
Children (Basel). 2022 Apr 9;9(4):534
. doi: 10.3390/children9040534. PMID: 35455578. Review. ˍ




Nguyen T, Mueller S, Malbari F.
Review: Neurological Complications From Therapies for Pediatric Brain Tumors.
Front Oncol. 2022 Apr 11;12:853034
. doi: 10.3389/fonc.2022.853034. PMID: 35480100. Review. ˍ




Sisakht AK, Malekan M, Ghobadinezhad F, Firouzabadi SNM, Jafari A, Mirazimi SMA, Abadi B, Shafabakhsh R, Mirzaei H.
Cellular Conversations in Glioblastoma Progression, Diagnosis and Treatment.
Cell Mol Neurobiol. 2022 Apr 11
. doi: 10.1007/s10571-022-01212-9. PMID: 35411434. Review˰ ˍ




Jaju A, Yeom KW, Ryan ME.
MR Imaging of Pediatric Brain Tumors.
Diagnostics (Basel). 2022 Apr 12;12(4):961
. doi: 10.3390/diagnostics12040961. PMID: 35454009. Review. ˍ




Saker Z, Rizk M, Bahmad HF, Nabha SM.
Targeting Angiogenic Factors for the Treatment of Medulloblastoma.
Curr Treat Options Oncol. 2022 Apr 12
. doi: 10.1007/s11864-022-00981-1. PMID: 35412196. Review˰ ˍ




Hua T, Zhuo Z, Duan Y, Li X, Gu H, Haller S, Zhang P, Liu X, Zhang L, Liu Y.
Prediction of H3 K27M-mutant in midline gliomas by magnetic resonance imaging: a systematic review and meta-analysis.
Neuroradiology. 2022 Apr 13
. doi: 10.1007/s00234-022-02947-4. PMID: 35416485. Review, Meta-analysis˰ ˍ




Mesbahi T, Zaine H, Mahazou Abdou I, Chekrine T, Sahraoui S, Karkouri M, Lakhdar A.
Glioblastoma Following Treated Medulloblastoma After 29 Years in the Posterior Fossa: Case Report and Review of Literature.
Front Oncol. 2022 Apr 13;12:760011
. doi: 10.3389/fonc.2022.760011. PMID: 35494079. Case report, Review. ˍ



*

Dono A, Nickles J, Rodriguez-Armendariz AG, McFarland BC, Ajami NJ, Ballester LY, Wargo JA, Esquenazi Y.
Glioma and the gut-brain axis: opportunities and future perspectives.
Neurooncol Adv. 2022 Apr 14, 2022 Jan-Dec;4(1):vdac054
. doi: 10.1093/noajnl/vdac054. PMID: 35591978. Review. ˍ



*

Maleki Dana P, Sadoughi F, Mirzaei H, Asemi Z, Yousefi B.
DNA damage response and repair in the development and treatment of brain tumors.
Eur J Pharmacol. 2022 Apr 14;924:174957
. doi: 10.1016/j.ejphar.2022.174957. PMID: 35430209. Review˰ ˍ




Shlobin NA, Montgomery EY, Mohammad LM, Kandula V, Beestrum M, DeCuypere M, Lam SK.
Visual Outcomes After Treatment for Sporadic Optic Pathway Gliomas in Pediatric Patients: A Systematic Review.
World Neurosurg. 2022 Apr 14:S1878-8750(22)00471-5
. doi: 10.1016/j.wneu.2022.04.033. PMID: 35430402. Review˰ ˍ




De Luca C, Virtuoso A, Papa M, Certo F, Barbagallo GMV, Altieri R.
Regional Development of Glioblastoma: The Anatomical Conundrum of Cancer Biology and Its Surgical Implication.
Cells. 2022 Apr 15;11(8):1349
. doi: 10.3390/cells11081349. PMID: 35456027. Review. ˍ



*

Germano IM, Johnson DR, Patrick HH, Goodman AL, Ziu M, Ormond DR, Olson JJ.
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Management of Progressive Glioblastoma in Adults: Update of the 2014 Guidelines.
Neurosurgery. 2022 Apr 15;90(5):e112-e115
. doi: 10.1227/neu.0000000000001903. PMID: 35426875. Review, Guidelines. ˍ




Rong L, Li N, Zhang Z.
Emerging therapies for glioblastoma: current state and future directions.
J Exp Clin Cancer Res. 2022 Apr 15;41(1):142
. doi: 10.1186/s13046-022-02349-7. PMID: 35428347. Review. ˍ




Stopa BM, Crowley J, Juhász C, Rogers CM, Witcher MR, Kiser JW.
Prostate-Specific Membrane Antigen as Target for Neuroimaging of Central Nervous System Tumors.
Mol Imaging. 2022 Apr 15;2022:5358545
. doi: 10.1155/2022/5358545. PMID: 35517711. Review. ˍ



*

Tamai S, Ichinose T, Tsutsui T, Tanaka S, Garaeva F, Sabit H, Nakada M.
Tumor Microenvironment in Glioma Invasion.
Brain Sci. 2022 Apr 15;12(4):505
. doi: 10.3390/brainsci12040505. PMID: 35448036. Review. ˍ